Keywords: lanoteplase, tested, intime, study, bristol-myers, squibb, new

Lanoteplase Tested In InTIME 2 Study

Article | 25 November 1997

Print This

Bristol-Myers Squibb's new thrombolytic lanoteplase (nPA) has nowentered Phase III testing in the InTIME 2 study. The study will compare the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in